SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE

Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 1

Abstract

In today scenario, as per market demand there is definitely carry out an increment or decrease in production, this is called SUPAC. Different guidelines are provided for those different types of SUPAC in by different regulatory authority for manufacturing of product. Here SUPAC guidelines for USFDA are elaborated for production in this review article.

Authors and Affiliations

Mounica N. V. N. , Sharmila Reddy V, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D, Brahmaiah B.

Keywords

Related Articles

A review on ANDA submission requirements for Generic drugs: “Paragraph IV certification” as per FDA CDER guidelines

USFDA is one the most regulated agencies wherein the submission process is most critical. The study depends on how to submit ANDA application as per FDA, CDER guidelines in paragraph IV submission in Federal Food, Drug,...

Saxagliptin and Dapagliflozin for type 2 Diabetes mellitus: A Review

Qtern® is a fixed dose combination tablet of Saxagliptin and Dapagliflozin which is indicated for the advancement of glycaemic control in adults with type 2 diabetes mellitus (T2DM). It can be done either when medication...

CONCEPT OF 505 (b) (2) APPLICATION: BENEFITS AND CHALLENGES

A 505(b) (2) application is a new drug application (NDA) delineated in section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act.505(b)(2) application is one that one or a lot of the investigations relied upon by the...

QbD APPROACH FOR STABILITY INDICATING HPLC METHOD FOR DETERMINATION OF ARTEMETHER AND LUMEFANTRINE IN COMBINED DOSAGE FORM

The present paper reports a highly selective, sensitive and robust stability indicating RP-HPLC method using QbD approach, developed and validated for determination of Artemether and Lumefantrine in combined dosage form....

SUPAC OF IMMEDIATE-RELEASE, MODIFIED- RELEASE AND SEMI-SOLID: A REGULATORY NOTE

In today scenario, as per market demand there is definitely carry out an increment or decrease in production, this is called SUPAC. Different guidelines are provided for those different types of SUPAC in by different reg...

Download PDF file
  • EP ID EP326650
  • DOI 10.22270/ijdra.v5i1.192
  • Views 185
  • Downloads 0

How To Cite

Mounica N. V. N. , Sharmila Reddy V, Evangeline L, Nagabhushanam M. V. , Nagarjunareddy D, Brahmaiah B. (2017). SCALE UP AND POSTAPPROVAL CHANGES (SUPAC) GUIDANCE FOR INDUSTRY: A REGULATORY NOTE. International Journal of Drug Regulatory Affairs, 5(1), 13-19. https://www.europub.co.uk/articles/-A-326650